Page last updated: 2024-10-29

avapro and Genetic Predisposition

avapro has been researched along with Genetic Predisposition in 3 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, S1
Wang, K1
Xu, G1
Ji, J1
Qin, C1
Jiang, S1
Venners, SA1
Hsu, YH1
Weinstock, J1
Wang, B1
Xing, H1
Wang, X1
Xu, X1
Wassmann, S1
Czech, T1
van Eickels, M1
Fleming, I1
Böhm, M1
Nickenig, G1

Other Studies

3 other studies available for avapro and Genetic Predisposition

ArticleYear
The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
    Pakistan journal of pharmaceutical sciences, 2016, Volume: 29, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Aor

2016
Interactive Effect of the KCNJ11 Ile337Val Polymorphism and Cigarette Smoking on the Antihypertensive Response to Irbesartan in Chinese Hypertensive Patients.
    American journal of hypertension, 2016, Volume: 29, Issue:5

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Bipheny

2016
Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Circulation, 2004, Nov-09, Volume: 110, Issue:19

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Arterioscleros

2004